Serum metabolomic signatures of relapse recovery in early multiple sclerosis

Key Points

• Recovery in multiple sclerosis correlates with distinct serum metabolomic signatures identified during relapse phases.
• The study identified over 30 unique metabolites associated with recovery, emphasizing the importance of metabolic pathways in disease management.
• Observational analysis across clinical settings established relationships between metabolomic profiles and clinical outcomes in multiple sclerosis.
• These findings highlight potential biomarkers that could enhance personalized treatment strategies in early multiple sclerosis recovery.